Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lorecivivint
2. N-(5-((3z)-3-(7-(3-fluorophenyl)imidazo(4,5-c)pyridin-2-ylidene)-1,2-dihydroindazol-5-yl)pyridin-3-yl)-3-methylbutanamide
3. Sm-04690
4. Sm04690
1. Lorecivivint
2. 1467093-03-3
3. Sm04690
4. Lorecivivint [usan]
5. N-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
6. Adavivint (sm04690)
7. Sm-04690
8. 42ek42whi5
9. 1467093-03-3 (free Base)
10. N-(5-(3-(7-(3-fluorophenyl)-3h-imidazo(4,5-c)pyridin-2-yl)-1h-indazol-5- Yl)-pyridin-3-yl)-3-methylbutanamide
11. Adavivint [inn]
12. N-[5-[3-[7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl]-1h-indazol-5-yl]pyridin-3-yl]-3-methylbutanamide
13. Adavivint; Sm04690
14. Lorecivivint (usan/inn)
15. Lorecivivint [inn]
16. Adavivint (deprecated Inn)
17. Unii-42ek42whi5
18. Gtpl9620
19. Chembl4297639
20. Schembl15302155
21. Bcp30409
22. Ex-a2711
23. Mfcd30489411
24. S8761
25. Who 10389
26. Db14883
27. Ac-31570
28. As-84223
29. Sm0-4690
30. Hy-109049
31. Cs-0031495
32. D11588
33. D83694
34. A934079
35. Sm04690; Sm-04690; Sm 04690 Pound>>cas:1467013-03-3
36. Butanamide, N-(5-(3-(7-(3-fluorophenyl)-3h-imidazo(4,5-c)pyridin-2-yl)-1h- Indazol-5-yl)-3-pyridinyl)-3-methyl-
37. N-(5-((3z)-3-(7-(3-fluorophenyl)imidazo(4,5-c)pyridin-2-ylidene)-1,2-dihydroindazol-5-yl)pyridin-3-yl)-3-methylbutanamide
38. N-(5-{3-[7-(3-fluorophenyl)-1h-imidazo[4,5-c]pyridin-2-yl]-1h-indazol-5-yl}pyridin-3-yl)-3-methylbutanamide
| Molecular Weight | 505.5 g/mol |
|---|---|
| Molecular Formula | C29H24FN7O |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 505.20263658 g/mol |
| Monoisotopic Mass | 505.20263658 g/mol |
| Topological Polar Surface Area | 112 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 816 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
98
PharmaCompass offers a list of Lorecivivint API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lorecivivint manufacturer or Lorecivivint supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lorecivivint manufacturer or Lorecivivint supplier.
PharmaCompass also assists you with knowing the Lorecivivint API Price utilized in the formulation of products. Lorecivivint API Price is not always fixed or binding as the Lorecivivint Price is obtained through a variety of data sources. The Lorecivivint Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lorecivivint manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lorecivivint, including repackagers and relabelers. The FDA regulates Lorecivivint manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lorecivivint API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lorecivivint supplier is an individual or a company that provides Lorecivivint active pharmaceutical ingredient (API) or Lorecivivint finished formulations upon request. The Lorecivivint suppliers may include Lorecivivint API manufacturers, exporters, distributors and traders.
Lorecivivint Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lorecivivint GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lorecivivint GMP manufacturer or Lorecivivint GMP API supplier for your needs.
A Lorecivivint CoA (Certificate of Analysis) is a formal document that attests to Lorecivivint's compliance with Lorecivivint specifications and serves as a tool for batch-level quality control.
Lorecivivint CoA mostly includes findings from lab analyses of a specific batch. For each Lorecivivint CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lorecivivint may be tested according to a variety of international standards, such as European Pharmacopoeia (Lorecivivint EP), Lorecivivint JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lorecivivint USP).
